First, FLT1 blockade interrupts pro-survival PGF-FLT1-AKT signaling in tumor cells, and second, it increases T-cell infiltration and the immune response, possibly by altering the tumor-cell secretome and chemokine milieu. This evidence concerns the gene FLT1 and neoplasm.